Prognostic utility of systemic immune-inflammation markers in locally advanced cervical cancer undergoing radical radiotherapy
The Oncologist · 10.04.2026 · 31 (5)
DOI: 10.1093/oncolo/oyag139 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 21.04.2026. Verfasst von Yue Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cance…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Inflammation, Biomarkers, Tumor. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wu Jieping Medical Foundation Clinical Research Fund, Jiangsu 333 High-level Talent Training Project, Key Medical Research Project of Jiangsu Provincial Health Commission in 2024.
Abstract (Originalsprache)
Purpose
To improve survival prediction in locally advanced cervical cancer (LACC) post-radiotherapy, we developed and compared a nomogram and machine learning (ML) models using immune-inflammatory markers. Material and Methods Clinical data from patients with LACC who received radical radiotherapy at our department between 2016 and 2019 were retrospectively analyzed. Key variables were selected using Spearman correlation and Boruta analysis. A Cox regression-based nomogram was developed and validated. ML models were also used to predict survival, with performance evaluated by accuracy, the area under the receiver operating characteristic curve (AUC), precision, recall, and the F1-score. The performance of the optimal ML model and the nomogram was compared using time-dependent predictive accuracy.
Results
A cohort of 300 patients with LACC was randomly allocated to training and validation cohorts at a 7:3 ratio. The nomogram and ML models incorporated immune-inflammatory markers and clinical variables. The nomogram demonstrated strong discriminative ability, calibration, and clinical utility, as evidenced by AUC, calibration plots, and decision curve analysis. Among ML models, logistic regression achieved superior performance (accuracy = 0.933, recall = 1.000, F1-score = 0.938). Time-dependent accuracy analysis revealed dynamic predictive performance over 12-60 months. The nomogram’s predictive accuracy improved over time, reaching 0.611 at 53-59 months, while logistic regression peaked earlier (0.911 at 12-24 months) and consistently outperformed the nomogram.
Conclusion
Both nomogram and ML models provide valuable prognostic insights for LACC. The logistic regression ML model showed superior predictive accuracy compared to the nomogram during 1-5 years of follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, China.
- Jiangsu Cancer Centre, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, China.
- Department of Gynecology, Women's Hospital of Nanjing Medical University & Nanjing Women and Children's Healthcare Hospital, Nanjing 210004, China.
- Center of Clinical Laboratory Science, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, China.
Förderung
- Wu Jieping Medical Foundation Clinical Research Fund
- Jiangsu 333 High-level Talent Training Project
- Key Medical Research Project of Jiangsu Provincial Health Commission in 2024
Zitieren
APA
Li, Y., Han, J., Xiao, S., Zhong, S., Liu, J., Li, H., Xie, X., Gong, Z., & Xu, H. (2026). Prognostic utility of systemic immune-inflammation markers in locally advanced cervical cancer undergoing radical radiotherapy. The Oncologist, 31(5). https://doi.org/10.1093/oncolo/oyag139
Vancouver
Li Y, Han J, Xiao S, Zhong S, Liu J, Li H, et al. Prognostic utility of systemic immune-inflammation markers in locally advanced cervical cancer undergoing radical radiotherapy. The Oncologist. 2026;31(5). doi:10.1093/oncolo/oyag139
BibTeX
@article{Li2026,
author = {Li, Yue and Han, Jing and Xiao, Shuyue and Zhong, Shanliang and Liu, Jianyao and Li, Huixin and Xie, Xinyi and Gong, Zhen and Xu, Hanzi},
title = {Prognostic utility of systemic immune-inflammation markers in locally advanced cervical cancer undergoing radical radiotherapy},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {5},
doi = {10.1093/oncolo/oyag139}
}
EUVIMED